Who
Malcolm Garret Hampton
Director
Company insider
Files Form 4 as: Director, IDEAYA Biosciences; Director, Quanterix; SVP Clinical Genomics Group, Illumina.
In numbers
- Trades disclosed
- 20
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 11 Dec 2017
- Last trade
- 16 Jun 2026
- Last filed
- 18 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 18 Jun 2026 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code A | —23,372 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code A | —23,372 at $0.00 | filing |
| 20 Nov 2025filed 25 Nov 2025 | QTRX QuanterixLife-science tools | SEC FORM 4 Code A | —46,727 | filing |
| 24 Jun 2025filed 26 Jun 2025 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 31 May 2024filed 31 May 2024 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,200 at $0.00 | filing |
| 7 Jun 2023filed 9 Jun 2023 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,200 at $0.00 | filing |
| 9 Jun 2022filed 10 Jun 2022 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,000 at $0.00 | filing |
| 10 Jun 2021filed 16 Jun 2021 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,000 at $0.00 | filing |
| 26 Jun 2020filed 30 Jun 2020 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 9 Jan 2020filed 13 Jan 2020 | ILMN IlluminaLife-science tools | SEC FORM 4 Code F | $109K326 at $334.60 | filing |
| 5 Nov 2019filed 7 Nov 2019 | ILMN IlluminaLife-science tools | SEC FORM 4 Code F | $148K492 at $300.87 | filing |
| 9 Jan 2019filed 11 Jan 2019 | ILMN IlluminaLife-science tools | SEC FORM 4 Code F | $100K327 at $305.24 | filing |
| 11 Dec 2018filed 13 Dec 2018 | ILMN Illuminaoption or derivative · Life-science tools | SEC FORM 4 Code A | —5,701 at $0.00 | filing |
| 11 Dec 2018filed 13 Dec 2018 | ILMN IlluminaLife-science tools | SEC FORM 4 Code A | —1,901 at $0.00 | filing |
| 5 Nov 2018filed 7 Nov 2018 | ILMN IlluminaLife-science tools | SEC FORM 4 Code F | $82K253 at $324.14 | filing |
| 9 Jan 2018filed 22 Mar 2019 | ILMN IlluminaLife-science tools | SEC FORM 4 Code F | $87K358 at $242.80 | filing |
| 11 Dec 2017filed 13 Dec 2017 | ILMN IlluminaLife-science tools | SEC FORM 4 Code A | —2,920 at $0.00 | filing |
| 11 Dec 2017filed 13 Dec 2017 | ILMN Illuminaoption or derivative · Life-science tools | SEC FORM 4 Code A | —8,758 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.